Valuation: Akeso, Inc.

Capitalization 7.49TCr 8.19TCr 1.04TCr 905.52Cr 852.97Cr 775.02Cr 1.43TCr 90TCr 1.62TCr 10TCr 3.87TCr 41TCr 3.92TCr 3.83TCr 1,52300Cr P/E ratio 2025 *
1,638x
P/E ratio 2026 * 84.3x
Enterprise value 7.3TCr 7.99TCr 1.02TCr 882.35Cr 831.15Cr 755.19Cr 1.4TCr 88TCr 1.57TCr 9.84TCr 3.77TCr 40TCr 3.82TCr 3.74TCr 1,48400Cr EV / Sales 2025 *
20.6x
EV / Sales 2026 * 13.4x
Free-Float
74.46%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.88%
1 week-8.45%
Current month+8.00%
1 month+8.84%
3 months+36.40%
6 months+50.83%
Current year+49.09%
More quotes
1 week 89
Extreme 89
103.4
1 month 73.1
Extreme 73.1
103.4
Current year 54
Extreme 54
105.5
1 year 35.2
Extreme 35.2
105.5
3 years 19.22
Extreme 19.22
105.5
5 years 11.5
Extreme 11.5
105.5
10 years 11.5
Extreme 11.5
105.5
More quotes
Manager TitleAgeSince
Corporate Officer/Principal 49 16/11/2019
Corporate Officer/Principal 56 16/11/2019
Chief Tech/Sci/R&D Officer 57 16/11/2019
Director TitleAgeSince
Chairman 58 19/03/2012
Director/Board Member 57 16/11/2019
Director/Board Member 56 16/11/2019
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.88%-8.45%+136.91%+273.97% 1.04TCr
-0.75%-3.69%-51.60%-13.14% 5.39TCr
-0.44%-6.27%+26.71%+39.09% 3.32TCr
+2.04%-0.04%+25.86%-13.85% 2.62TCr
+0.52%-4.39%+61.20%-30.38% 2.61TCr
+3.24%+4.00%+51.02%+427.38% 1.95TCr
+1.98%+3.94%+159.27%+1,803.70% 1.53TCr
-1.78%-7.02%-23.75%-35.98% 1.31TCr
-3.11%-12.45%+95.95%-66.83% 1.25TCr
-0.91%-2.93%+81.85%+99.95% 1.1TCr
Average -0.07%-3.53%+56.34%+248.39% 2.21TCr
Weighted average by Cap. +0.07%-3.34%+31.76%+171.69%
See all sector performances

Financials

2025 *2026 *
Net sales 355.27Cr 388.48Cr 49Cr 43Cr 40Cr 37Cr 68Cr 4.29TCr 77Cr 478.82Cr 183.24Cr 1.96TCr 185.7Cr 181.74Cr 7.22TCr 538.28Cr 588.61Cr 75Cr 65Cr 61Cr 56Cr 102.99Cr 6.49TCr 116.04Cr 725.49Cr 277.64Cr 2.98TCr 281.36Cr 275.37Cr 11TCr
Net income 5.55Cr 6.06Cr 77.25L 67L 63.12L 57.35L 1.06Cr 67Cr 1.2Cr 7.47Cr 2.86Cr 31Cr 2.9Cr 2.84Cr 112.67Cr 87Cr 95Cr 12Cr 11Cr 9.93Cr 9.03Cr 17Cr 1.05TCr 19Cr 117.64Cr 45Cr 482.43Cr 46Cr 45Cr 1.77TCr
Net Debt -191.76Cr -209.69Cr -27Cr -23Cr -22Cr -20Cr -37Cr -2.31TCr -41Cr -258.46Cr -99Cr -1.06TCr -100.23Cr -98Cr -3.9TCr -307.75Cr -336.52Cr -43Cr -37Cr -35Cr -32Cr -59Cr -3.71TCr -66Cr -414.78Cr -158.74Cr -1.7TCr -160.86Cr -157.44Cr -6.25TCr
More financial data * Estimated data
Logo Akeso, Inc.
Akeso Inc is an investment holding company mainly engaged in the research and development, production and commercialization of biopharmaceutical products. The Company is committed to the research, development, manufacturing and commercialization of innovative antibody drugs that are affordable to patients worldwide. The Company's products mainly include cadonilimab (PD-1/CTLA-4), Ivonescimab (AK112, PD-1/VEGF), ANNIKO (penpulimab, PD-1), Ebronucimab (AK102, PCSK9) and ebdarokimab (AK101, IL-12/IL-23). The Company's products are principally used to treat tumors, autoimmune diseases, metabolic diseases, as well as neurodegenerative diseases. The Company principally conducts its businesses in Mainland China, the United States and other markets.
Employees
3,035
More about the company
Date Price Change Volume
23/25/23 90.50 $ -0.88% 24,60,466
20/25/20 91.30 $ -0.81% 80,93,143
19/25/19 92.05 $ -2.85% 1,10,70,600
18/25/18 94.75 $ +0.74% 96,89,177
17/25/17 94.05 $ -4.86% 1,96,31,920

Delayed Quote Hong Kong S.E., June 23, 2025 at 08:04 am IST

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
83.49CNY
Average target price
96.17CNY
Spread / Average Target
+15.19%
Consensus

Quarterly revenue - Rate of surprise